Zerlasiran-A Small-Interfering RNA Targeting Lipoprotein(a): A Phase 2 Randomized Clinical Trial.
Nissen SE, Wang Q, Nicholls SJ, Navar AM, Ray KK, Schwartz GG, Szarek M, Stroes ESG, Troquay R, Dorresteijn JAN, Fok H, Rider DA, Romano S, Wolski K, Rambaran C.
Nissen SE, et al. Among authors: romano s.
JAMA. 2024 Nov 18:e2421957. doi: 10.1001/jama.2024.21957. Online ahead of print.
JAMA. 2024.
PMID: 39556769